INCYTE CORP - Common Stock (INCY)

CUSIP: 45337C102

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock
Shares outstanding
197,618,645
Total 13F shares
190,422,517
Share change
+27,384,047
Total reported value
$25,453,664,750
Put/Call ratio
93%
Price per share
$133.67
Number of holders
502
Value change
+$3,704,034,157
Number of buys
280
Number of sells
197

Security key

45337C102

Report period

Q1 2017

Institutions

502

Top holders

10

Top shareholders of INCY - INCYTE CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
12%
23,499,087
$2,356,253,000 31 Dec 2016
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
9.1%
18,060,127
$1,810,889,000 31 Dec 2016
13F
VANGUARD GROUP INC
13F
Company
6.4%
12,567,950
$1,260,188,000 31 Dec 2016
13F
Capital World Investors
13F
Company
5.2%
10,301,491
$1,032,931,000 31 Dec 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.6%
7,030,994
$704,998,000 31 Dec 2016
13F
Capital International Investors
13F
Company
3%
6,021,520
$603,778,000 31 Dec 2016
13F
BlackRock Fund Advisors
13F
Company
2.2%
4,436,973
$444,895,000 31 Dec 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
2.2%
4,435,321
$444,730,000 31 Dec 2016
13F
BB BIOTECH AG
13F
Company
2%
3,879,822
$389,030,000 31 Dec 2016
13F
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
3,652,652
$366,251,000 31 Dec 2016
13F
STATE STREET CORP
13F
Company
1.8%
3,598,477
$360,825,000 31 Dec 2016
13F
FRANKLIN RESOURCES INC
13F
Company
1.5%
2,959,613
$296,778,000 31 Dec 2016
13F
FMR LLC
13F
Company
1.4%
2,760,941
$276,839,000 31 Dec 2016
13F
BROWN CAPITAL MANAGEMENT LLC
13F
Company
1.3%
2,643,420
$265,056,000 31 Dec 2016
13F
Invesco Ltd.
13F
Company
1.2%
2,435,283
$244,186,000 31 Dec 2016
13F
CITADEL ADVISORS LLC
13F
Company
1.1%
2,203,481
$220,943,000 31 Dec 2016
13F
ORBIMED ADVISORS LLC
13F
Company
1.1%
2,082,800
$208,842,000 31 Dec 2016
13F
CAPITAL GUARDIAN TRUST CO
13F
Company
0.97%
1,926,691
$193,189,000 31 Dec 2016
13F
NORGES BANK
13F
Company
0.91%
1,800,739
$180,561,000 31 Dec 2016
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.89%
1,765,425
$177,019,000 31 Dec 2016
13F
JPMORGAN CHASE & CO
13F
Company
0.76%
1,497,260
$150,294,000 31 Dec 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
1,416,905
$142,074,000 31 Dec 2016
13F
Matrix Capital Management Company, LP
13F
Company
0.71%
1,400,000
$140,378,000 31 Dec 2016
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.65%
1,284,135
$128,760,000 31 Dec 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.63%
1,253,901
$125,688,000 31 Dec 2016
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.6%
1,192,665
$119,588,000 31 Dec 2016
13F
Bank of New York Mellon Corp
13F
Company
0.58%
1,153,229
$115,634,000 31 Dec 2016
13F
BlackRock Group LTD
13F
Company
0.57%
1,130,737
$113,379,000 31 Dec 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.57%
1,120,834
$112,382,000 31 Dec 2016
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.56%
1,104,616
$110,760,000 31 Dec 2016
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.56%
1,103,562
$110,656,000 31 Dec 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.56%
1,100,151
$110,313,000 31 Dec 2016
13F
NORTHERN TRUST CORP
13F
Company
0.5%
979,102
$98,175,000 31 Dec 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.48%
944,258
$94,681,000 31 Dec 2016
13F
MARSHALL WACE, LLP
13F
Company
0.48%
940,303
$94,285,000 31 Dec 2016
13F
JENNISON ASSOCIATES LLC
13F
Company
0.47%
936,212
$93,874,000 31 Dec 2016
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.45%
880,946
$88,332,000 31 Dec 2016
13F
Tekla Capital Management LLC
13F
Company
0.45%
880,461
$88,284,000 31 Dec 2016
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.41%
803,142
$80,531,000 31 Dec 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.39%
763,100
$76,516,000 31 Dec 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.38%
742,975
$74,498,000 31 Dec 2016
13F
HealthCor Management, L.P.
13F
Company
0.38%
741,360
$74,336,000 31 Dec 2016
13F
VIKING GLOBAL INVESTORS LP
13F
Company
0.37%
730,452
$73,242,000 31 Dec 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.34%
679,928
$68,177,000 31 Dec 2016
13F
1832 Asset Management L.P.
13F
Company
0.34%
674,600
$66,191,000 31 Dec 2016
13F
Legal & General Group Plc
13F
Company
0.34%
662,144
$66,393,000 31 Dec 2016
13F
Artal Group S.A.
13F
Company
0.33%
650,000
$65,176,000 31 Dec 2016
13F
AMUNDI ASSET MANAGEMENT US, INC.
13F
Company
0.32%
623,117
$62,480,000 31 Dec 2016
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.31%
609,490
$61,114,000 31 Dec 2016
13F
Alyeska Investment Group, L.P.
13F
Company
0.3%
586,290
$58,787,000 31 Dec 2016
13F

Institutional Holders of INCYTE CORP - Common Stock (INCY) as of Q1 2017

As of 31 Mar 2017, INCYTE CORP - Common Stock (INCY) was held by 502 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 190,422,517 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Capital World Investors, Capital International Investors, SANDS CAPITAL MANAGEMENT, LLC, and BB BIOTECH AG. This page lists 502 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
422
Q1 2017 holders
502
Holder diff
80
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 Value $ Q1 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .